STOCK TITAN

Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Spectral AI, Inc. (Nasdaq: MDAI) has scheduled its 2024 first quarter financial results release for May 7, 2024. The company specializes in AI for medical diagnostics in wound care, aiming for faster and more precise treatment decisions. Investors can join the conference call at 5:00 pm Eastern Time to discuss the results.
Spectral AI, Inc. (Nasdaq: MDAI) ha programmato la pubblicazione dei risultati finanziari del primo trimestre del 2024 per il 7 maggio 2024. L'azienda è specializzata in intelligenza artificiale per la diagnostica medica nella cura delle ferite, puntando a decisioni di trattamento più rapide e precise. Gli investitori possono partecipare alla teleconferenza alle 17:00, ora della costa orientale, per discutere i risultati.
Spectral AI, Inc. (Nasdaq: MDAI) ha programado la publicación de los resultados financieros del primer trimestre de 2024 para el 7 de mayo de 2024. La compañía se especializa en IA para diagnósticos médicos en el cuidado de heridas, buscando decisiones de tratamiento más rápidas y precisas. Los inversores pueden unirse a la llamada de conferencia a las 5:00 p.m. hora del Este para discutir los resultados.
Spectral AI, Inc. (나스닥: MDAI)는 2024년 1분기 재무 결과를 2024년 5월 7일에 발표할 예정입니다. 이 회사는 상처 치료 분야의 의료 진단을 위한 인공 지능에 특화되어 있으며, 더 빠르고 정확한 치료 결정을 목표로 하고 있습니다. 투자자들은 동부 표준시 오후 5시에 결과를 논의하기 위한 컨퍼런스 콜에 참여할 수 있습니다.
Spectral AI, Inc. (Nasdaq : MDAI) a programmé la publication de ses résultats financiers pour le premier trimestre 2024 pour le 7 mai 2024. L'entreprise est spécialisée dans l'IA pour le diagnostic médical dans le soin des plaies, visant à rendre les décisions de traitement plus rapides et précises. Les investisseurs peuvent rejoindre l'appel conférence à 17h00 heure de l'Est pour discuter des résultats.
Spectral AI, Inc. (Nasdaq: MDAI) hat die Veröffentlichung seiner Finanzergebnisse für das erste Quartal 2024 für den 7. Mai 2024 angesetzt. Das Unternehmen ist spezialisiert auf KI für medizinische Diagnostik in der Wundpflege, mit dem Ziel, schnellere und genauere Behandlungsentscheidungen zu ermöglichen. Investoren können sich um 17:00 Uhr Ostküstenzeit in eine Telefonkonferenz einwählen, um die Ergebnisse zu besprechen.
Positive
  • None.
Negative
  • None.

DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the first quarter ended March 31, 2024 on Tuesday, May 7, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results.

Investors interested in participating in the live call can dial:

  • 833-630-1956 - U.S.
  • 412-317-1837 - International

A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events

About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal to change current standard of care in the future, DeepView® is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView®, visit www.spectral-ai.com.

Forward Looking Statements

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.

These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.

Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.

Contacts:
 
  
Investors
 
Equity Group
 
Devin SullivanConor Rodriguez
Managing DirectorAnalyst
dsullivan@equityny.comcrodriguez@equityny.com
  
Media
 
Russo Partners
 
David Schull 
david.schull@russopartnersllc.com 
(858) 717-2310 


FAQ

When will Spectral AI announce its 2024 first quarter financial results?

Spectral AI will report its financial results for the first quarter ended March 31, 2024 on Tuesday, May 7, 2024 after the close of the stock market.

What is Spectral AI focused on in terms of its AI technology?

Spectral AI is focused on medical diagnostics for faster and more accurate treatment decisions in wound care using artificial intelligence.

How can investors participate in the conference call to discuss the financial results?

Investors interested in participating in the live call can dial: 833-630-1956 for U.S. and 412-317-1837 for International. A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company’s website.

Spectral AI, Inc.

NASDAQ:MDAI

MDAI Rankings

MDAI Latest News

MDAI Stock Data

26.23M
18.51M
46.74%
21.01%
5.07%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
DALLAS